Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A novel and low-toxic peptide DR3penA alleviates pulmonary fibrosis by regulating the MAPK/miR-23b-5p/AQP5 signaling axis
Dan Wang, Bochuan Deng, Lü Cheng, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 2, pp. 722-738
Open Access | Times Cited: 13

Showing 13 citing articles:

SOX9 Induces Orbital Fibroblast Activation in Thyroid Eye Disease Via MAPK/ERK1/2 Pathway
Min Zhou, Bingying Lin, Pengsen Wu, et al.
Investigative Ophthalmology & Visual Science (2024) Vol. 65, Iss. 2, pp. 25-25
Open Access | Times Cited: 5
Iterative Optimization Yields Stapled Peptides with Superior Pharmacokinetics and Potency for Renal Fibrosis Treatment
Bochuan Deng, Ping Su, Cheng Lu, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
An anti-complement homogeneous polysaccharide from Houttuynia cordata ameliorates acute pneumonia with H1N1 and MRSA coinfection through rectifying Treg/Th17 imbalance in the gut–lung axis and NLRP3 inflammasome activation
Xinxing Li, Wenxin Ding, Yan Lu, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis
Muttanagouda Giriyappagoudar, Basavaraj Vastrad, Rajeshwari Horakeri, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3109-3109
Open Access | Times Cited: 7
Spatially resolved metabolomics visualizes heterogeneous distribution of metabolites in lung tissue and the anti-pulmonary fibrosis effect of Prismatomeris connate extract
Haiyan Jiang, Bowen Zheng, Guang Hu, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 9, pp. 100971-100971
Open Access | Times Cited: 1
Study on potential differentially expressed genes in idiopathic pulmonary fibrosis by bioinformatics and next generation sequencing data analysis
Basavaraj Vastrad, Chanabasayya Vastrad
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Novel Peptide DR3penA as a Low-Toxicity Antirenal Fibrosis Agent by Suppressing the TGF-β1/miR-212-5p/Low-Density Lipoprotein Receptor Class a Domain Containing 4/Smad Axis
Bochuan Deng, Jiao Zhang, Xiang Zhang, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 4, pp. 1126-1141
Open Access
A synthetic peptide, derived from neurotoxin GsMTx4, acts as a non-opioid analgesic to alleviate mechanical and neuropathic pain through the TRPV4 channel
Shao-Xi Ke, Ping Dong, Yunqing Mei, et al.
Acta Pharmaceutica Sinica B (2024)
Open Access
Progranulin: A promising biomarker and therapeutic target for fibrotic diseases
Fan Yang, Ming-Han Cheng, Hai‐Feng Pan, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3312-3326
Open Access
Mesenchymal Stem Cell-Exosomal miR-99a Attenuate Silica-Induced Lung Fibrosis by Inhibiting Pulmonary Fibroblast Transdifferentiation
Xiaohui Hao, Peiyuan Li, Yudi Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12626-12626
Open Access
The application and prospects of drug delivery systems in idiopathic pulmonary fibrosis
Xi Zhang, Ling Zhang, Jia-Hua Tian, et al.
Biomaterials Advances (2024) Vol. 168, pp. 214123-214123
Closed Access
The novel peptide DR4penA attenuates the bleomycin‐ and paraquat‐induced pulmonary fibrosis by suppressing the TGF‐β/Smad signaling pathway
Dan Wang, Bochuan Deng, Lu Cheng, et al.
The FASEB Journal (2023) Vol. 37, Iss. 11
Closed Access | Times Cited: 1
The peptide DR3penA exhibits antifibrotic activity in multiple pulmonary fibrosis models induced by particulate and soluble chemical fibrogenic agents
Jieru Li, Bochuan Deng, Jiao Zhang, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 388, Iss. 2, pp. 701-714
Open Access | Times Cited: 1
A network pharmacology approach to explore the molecular mechanism of active peptide ingredients of Carapax Trionycis on liver fibrosis
Zhibin Yan, Guangyu Zhao, Qihao Lin, et al.
Peptide Science (2023) Vol. 116, Iss. 2
Open Access
Mesenchymal Stem Cell-Derived Exosomes Attenuate SiO2-Induced Pulmonary Fibrosis by Inhibiting Pulmonary Fibroblast Transdifferentiation Through miR-99a
Peiyuan Li, Xiaohui Hao, Xuemin Gao, et al.
(2023)
Closed Access
Page 1

Scroll to top